|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_NoncurrentFinancialAssetAcquisitionAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_BoardDecisionDateForAcquisition|
|
|
03/06/2024
|
|||||||
|
oda_WereMajorityOfIndependentBoardMembersApprovedTheBoardDecisionForAcquisition|
|
|
Yes
|
|||||||
|
oda_TitleOfNoncurrentFinancialAssetAcquired|
|
|
Invios Holding AG
|
|||||||
|
oda_FieldOfActivityNoncurrentFinancialAssetWhoseSharesWereAcquired|
|
|
Drug research and development
|
|||||||
|
oda_CapitalOfNoncurrentFinancialAsset|
|
|
5.334.668,00 EUR
|
|||||||
|
oda_AcquirementWay|
|
|
Sermaye Artırımı Yoluyla Edinim (Capital Increase)
|
|||||||
|
oda_DateOnWhichTheTransactionWasWillBeCompleted|
|
|
19.09.2024
|
|||||||
|
oda_AcquisitionConditions|
|
|
Peşin (Cash)
|
|||||||
|
oda_DetailedConditionsIfItIsATimedPayment|
|
|
-
|
|||||||
|
oda_NominalValueOfSharesAcquired|
|
|
25.000,00 EUR
|
|||||||
|
oda_PurchasePricePerShare|
|
|
5,00 EUR
|
|||||||
|
oda_TotalPurchasingValue|
|
|
125.000,00 EUR
|
|||||||
|
oda_RatioOfNewSharesAcquiredToCapitalOfNoncurrentFinancialAsset|
|
|
0,46
|
|||||||
|
oda_TotalRatioOfSharesOwnedInCapitalOfNoncurrentFinancialAssetAfterTransaction|
|
|
0,979
|
|||||||
|
oda_TotalVotingRightRatioOwnedInNoncurrentFinancialAssetAfterTransaction|
|
|
0,979
|
|||||||
|
oda_RatioOfNoncurrentFinancialAssetAcquiredToTotalAssetsInLatestDisclosedFinancialStatementsOfCompany|
|
|
0,047
|
|||||||
|
oda_RatioOfTransactionValueToSalesInLatestAnnualFinancialStatementsOfCompany|
|
|
0,057
|
|||||||
|
oda_EffectsOnCompanyOperations|
|
|
Positive impact is expected
|
|||||||
|
oda_DidTakeoverBidObligationArised|
|
|
Hayır (No)
|
|||||||
|
oda_WillExemptionApplicationBeMadeIfTakeoverBidObligationArised|
|
|
Hayır (No)
|
|||||||
|
oda_TitleNameSurnameOfCounterParty|
|
|
-
|
|||||||
|
oda_IsCounterPartyARelatedPartyAccordingToCMBRegulations|
|
|
Evet (Yes)
|
|||||||
|
oda_RelationWithCounterPartyIfAny|
|
|
GEN already shareholder of the company
|
|||||||
|
oda_AgreementSigningDateIfExists|
|
|
|
|||||||
|
oda_ValueDeterminationMethodOfNoncurrentFinancialAsset|
|
|
Negotiation
|
|||||||
|
oda_DidValuationReportBePrepared|
|
|
Düzenlenmedi (Not Prepared)
|
|||||||
|
oda_ReasonForNotPreparingValuationReportIfItWasNotPrepared|
|
|
Not obligatory
|
|||||||
|
oda_DateAndNumberOfValuationReport|
|
|
-
|
|||||||
|
oda_TitleOfValuationCompanyPreparedReport|
|
|
-
|
|||||||
|
oda_ValueDeterminedInValuationReportIfExists|
|
|
-
|
|||||||
|
oda_ReasonsIfTransactionWasntWillNotBePerformedInAccordanceWithValuationReport|
|
|
-
|
|||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
Our company joined capital increase process of Invios Holding AG which is one of GEN's financial assets as a result of the capital increase process GEN's shares on Invios Holding AG from 0,566% to 0,979%
|
||||||||